The Journal of Allergy and Clinical Immunology
-
Publication Venue For
-
Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantation..
151:260-271.
2023
-
Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis.
2022
-
The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions.
2022
-
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions.
2022
-
Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis..
150:1097-1105.e12.
2022
-
Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.
2022
-
Introducing thymus for promoting transplantation tolerance..
150:549-556.
2022
-
Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees..
149:1525-1560.
2022
-
Experience with cultured thymus tissue in 105 children..
149:747-757.
2022
-
Comprehensive analysis of ADA2 genetic variants and estimation of carrier frequency driven by a function-based approach..
149:379-387.
2022
-
Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines..
147:2075-2082.e2.
2021
-
Immune phenotypes in individuals positive for antinuclear antibodies: The impact of race and ethnicity..
146:1346-1348.
2020
-
Ventilation defects on hyperpolarized helium-3 MRI in asthma are predictive of 2-year exacerbation frequency..
146:831-839.e6.
2020
-
Noncanonical autophagy in dermal dendritic cells mediates immunosuppressive effects of UV exposure..
145:1389-1405.
2020
-
Untargeted metabolomic profiling identifies disease-specific signatures in food allergy and asthma..
145:897-906.
2020
-
Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: A working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology..
145:46-69.
2020
-
Epigenome-wide meta-analysis of DNA methylation and childhood asthma..
143:2062-2074.
2019
-
Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency..
143:852-863.
2019
-
The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)..
143:405-407.
2019
-
Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations..
142:1665-1669.
2018
-
Outcome of domino hematopoietic stem cell transplantation in human subjects: An international case series..
142:1628-1631.e4.
2018
-
Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2..
142:1363-1365.e8.
2018
-
Glutathione and arginine levels: Predictors for acetaminophen-associated asthma exacerbation?.
142:308-311.e9.
2018
-
Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease..
141:2037-2047.e10.
2018
-
Reprograming immunity to food allergens..
141:1936-1939.e2.
2018
-
ADA2 deficiency: Clonal lymphoproliferation in a subset of patients..
141:1534-1537.e8.
2018
-
Overweight/obesity status in preschool children associates with worse asthma but robust improvement on inhaled corticosteroids..
141:1459-1467.e2.
2018
-
Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry..
141:1028-1035.
2018
-
Obese asthmatic patients have decreased surfactant protein A levels: Mechanisms and implications..
141:918-926.e3.
2018
-
Obesity's effect on asthma extends to diagnostic criteria..
141:1096-1104.
2018
-
Ventilation defect percent in helium-3 magnetic resonance imaging as a biomarker of severe outcomes in asthma..
141:1140-1141.e4.
2018
-
Effect of endotoxin and alum adjuvant vaccine on peanut allergy..
141:791-794.e8.
2018
-
Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders..
141:322-328.e10.
2018
-
Thymus transplantation for complete DiGeorge syndrome: European experience..
140:1660-1670.e16.
2017
-
Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment..
140:63-75.
2017
-
Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation..
139:1282-1292.
2017
-
Individualized therapy for persistent asthma in young children..
138:1608-1618.e12.
2016
-
Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer..
138:1712-1715.
2016
-
Ozone primes alveolar macrophage-derived innate immunity in healthy human subjects..
138:1213-1215.e1.
2016
-
Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation..
138:628-630.e2.
2016
-
Pre-existing anti-polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer..
137:1610-1613.e7.
2016
-
Correction notice for TNF-R on mast cells regulate airway responses to Mycoplasma pneumoniae..
137:336.
2016
-
Clinical application of whole-genome sequencing in patients with primary immunodeficiency..
136:476-9.e6.
2015
-
Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease..
135:1519-28.e8.
2015
-
Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction..
135:1063-1065.e5.
2015
-
Overweight children report qualitatively distinct asthma symptoms: analysis of validated symptom measures..
135:886-893.e3.
2015
-
Tolerance and immunity after sequential lung and bone marrow transplantation from an unrelated cadaveric donor..
135:567-570.
2015
-
Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency..
135:283-7.e5.
2015
-
Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis..
134:1084-1092.e1.
2014
-
Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency..
134:935-943.e15.
2014
-
Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots..
134:155-159.
2014
-
Progress in HIV-1 vaccine development..
134:3-10.
2014
-
A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency..
133:1099-1108.
2014
-
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience..
133:1092-1098.
2014
-
Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development..
133:1109-1115.
2014
-
Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts..
133:961-966.
2014
-
Childhood asthma clusters and response to therapy in clinical trials..
133:363-369.
2014
-
Primary Immune Deficiency Treatment Consortium (PIDTC) report..
133:335-347.
2014
-
Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy..
133:468-475.
2014
-
Elevated IgE and atopy in patients treated for early-onset ADA-SCID..
132:1444-1446.
2013
-
A new nucleic acid-based agent inhibits cytotoxic T lymphocyte-mediated immune disorders..
132:713-722.e11.
2013
-
High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders..
132:378-386.
2013
-
Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison..
132:476-8.e2.
2013
-
Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome..
131:1611-1623.
2013
-
Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency..
131:1604-1610.
2013
-
Asthma and the host-microbe interaction..
131:1449-50.e3.
2013
-
B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment?.
131:994-1000.
2013
-
Delayed-onset adenosine deaminase deficiency: strategies for an early diagnosis..
130:991-994.
2012
-
IL-13 in asthma and allergic disease: asthma phenotypes and targeted therapies..
130:829-842.
2012
-
Pepsinized cashew proteins are hypoallergenic and immunogenic and provide effective immunotherapy in mice with cashew allergy..
130:716-723.
2012
-
Mast cell TNF receptors regulate responses to Mycoplasma pneumoniae in surfactant protein A (SP-A)-/- mice..
130:205-14.e2.
2012
-
Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome..
129:1562-9.e5.
2012
-
Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy..
129:1159-1162.
2012
-
The long quest for neonatal screening for severe combined immunodeficiency..
129:597-604.
2012
-
Interpreting low T-cell receptor excision circles in newborns with DiGeorge anomaly: importance of assessing naive T-cell markers..
128:1375-1376.
2011
-
Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome..
128:1266-1276.e11.
2011
-
Systemic exposure to fluticasone MDI delivered through antistatic chambers..
128:1113-5.e1-3.
2011
-
Early-onset monocyte-B-natural killer-dendritic cells' deficiency successfully treated with hematopoietic stem cell transplantation..
128:897-900.e1.
2011
-
Role of hyaluronan and hyaluronan-binding proteins in human asthma..
128:403-411.e3.
2011
-
Diacylglycerol kinase ζ deficiency in a non-CD4(+) T-cell compartment leads to increased peanut hypersensitivity..
128:212-214.
2011
-
Eosinophilic esophagitis: updated consensus recommendations for children and adults..
128:3-20.e6.
2011
-
Genome-wide association identifies diverse causes of common variable immunodeficiency..
127:1360-7.e6.
2011
-
Induction of tolerance to parental parathyroid grafts using allogeneic thymus tissue in patients with DiGeorge anomaly..
127:1351-1355.
2011
-
α4β7 Integrin is essential for contact hypersensitivity by regulating migration of T cells to skin..
126:1267-1276.
2010
-
Mechanisms of tolerance to parental parathyroid tissue when combined with human allogeneic thymus transplantation..
126:814-820.e8.
2010
-
Regulatory B cells that produce IL-10: a breath of fresh air in allergic airway disease..
125:1125-1127.
2010
-
B-cell function in severe combined immunodeficiency after stem cell or gene therapy: a review..
125:790-797.
2010
-
Transplantation immunology: solid organ and bone marrow..
125:S324-S335.
2010
-
Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management..
124:1152-60.e12.
2009
-
Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning..
124:1062-9.e1-4.
2009
-
Comèl-Netherton syndrome defined as primary immunodeficiency..
124:536-543.
2009
-
Clinical efficacy and immune regulation with peanut oral immunotherapy..
124:292-300.97.
2009
-
Safety of a peanut oral immunotherapy protocol in children with peanut allergy..
124:286-291.e6.
2009
-
A desensitization protocol for the mAb cetuximab..
123:260-262.
2009
-
Impairing oral tolerance promotes allergy and anaphylaxis: a new murine food allergy model..
123:231-238.e4.
2009
-
Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs..
122:1087-1096.
2008
-
Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb..
122:1185-1193.
2008
-
Methicillin-susceptible Staphylococcus aureus brain abscess in common variable immunodeficiency after an 8-month gap in return to the immunologist..
122:1036-1037.
2008
-
A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma..
122:78-85.
2008
-
Antiretroviral therapy corrects HIV-1-induced expansion of CD8+ CD45RA+ CD2-) CD11a(bright) activated T cells..
122:166-172.e2.
2008
-
Critical issues in mucosal immunity for HIV-1 vaccine development..
122:3-9.
2008
-
Normative values for exhaled breath condensate pH and its relationship to exhaled nitric oxide in healthy African Americans..
122:101-106.
2008
-
Treatment of infants with complete DiGeorge anomaly..
121:1063.
2008
-
Determinants of exhaled nitric oxide levels in healthy, nonsmoking African American adults..
121:396-402.e3.
2008
-
B cell-directed therapies for autoimmune disease and correlates of disease response and relapse..
121:13-21.
2008
-
Epigallocatechin gallate affects human dendritic cell differentiation and maturation..
121:209-214.
2008
-
Symposium on the Definition and Management of Anaphylaxis: Summary report.
115:584-591.
2005
-
Physiologic response to chronic house dust mite exposure in mice is dependent on lot characteristics.
2019